CRNX Operating Income Growth

Crinetics Pharmaceuticals Inc · Operating Income Growth

CRNX logo

CRNX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-29.79%
CRNX TTM Operating Income YoY % (-214.56% → -29.79%)
High-resolution chart · PNG

CRNX operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Crinetics Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-29.7902%
-44.8629%
-52.5049%
-55.769%
-52.2085%
-51.8099%
-52.22%
-47.8352%
-44.7769%
-36.3264%
-32.5979%
-37.2267%
-41.6148%
-53.4706%
-55.8764%
-53.3533%
-51.8975%
-48.099%
-43.6927%
-44.21%
-36.9816%
-30.078%
-39.235%
-42.3047%
-59.3397%
-85.2955%
-87.5026%
-120.6107%
-154.2278%
-175.8884%
-214.5612%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.